The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Biomea Fusion, Inc.(NASDAQ:BMEA)


Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibit...
Website: http://www.biomeafusion.com
Founded: 2017
CEO: Thomas Butler
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Biomea Fusion . Days Payable Outstanding ttm (DPO)
Biomea Fusion . Op Cashflow Per Share ttm
Biomea Fusion . Free Cashflow Per Share ttm
Biomea Fusion . Cash Per Share ttm
Biomea Fusion . (GAAP) P/E ratio ttm
Biomea Fusion . P/B ratio ttm
No extra charts and metrics for this ticker.